Found: 7
Select item for more details and to access through your institution.
Trastuzumab Emtansine (T-DM1): A Novel Agent for Targeting HER2+ Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2011, v. 11, n. 5, p. 275, doi. 10.1016/j.clbc.2011.03.018
- By:
- Publication type:
- Article
Arterial Thromboembolic Events in Patients with Metastatic Carcinoma Treated with Chemotherapy and Bevacizumab.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2007, v. 99, n. 16, p. 1232, doi. 10.1093/jnci/djm086
- By:
- Publication type:
- Article
Association of k-ras, b-raf, and p53 Status With the Treatment Effect of Bevacizumab.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 13, p. 981, doi. 10.1093/jnci/dji174
- By:
- Publication type:
- Article
A phase I pharmacological and biological study of PI-88 and docetaxel in patients with advanced malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 63, n. 1, p. 65, doi. 10.1007/s00280-008-0712-z
- By:
- Publication type:
- Article
Safety and pharmacokinetic study of RPI.4610 (ANGIOZYME), an anti-VEGFR-1 ribozyme, in combination with carboplatin and paclitaxel in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 4, p. 329, doi. 10.1007/s00280-004-0968-x
- By:
- Publication type:
- Article
Analysis of docetaxel pharmacokinetics in humans with the inclusion of later sampling time-points afforded by the use of a sensitive tandem LCMS assay.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2003, v. 52, n. 2, p. 159, doi. 10.1007/s00280-003-0622-z
- By:
- Publication type:
- Article
A phase 1 study of weekly dosing of trastuzumab emtansine (T-DM1) in patients with advanced human epidermal growth factor 2-positive breast cancer.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 23, p. 5733, doi. 10.1002/cncr.27622
- By:
- Publication type:
- Article